Mass. Movers

Abiomed results come up short in quarter

Abiomed’s Impella heart pump

Abiomed’s Impella heart pump

Danvers-based Abiomed Inc., a provider of heart support technologies, said that physicians have implanted more than 15,000 of its Impella pumps in US patients.

But shares fell on first-quarter 2014 revenue of $42.7 million, up 10 percent over the same period last year but short of analysts’ estimates of $42.93 million.

The per share loss was 4 cents, compared to 8 cents in the prior period. First-quarter worldwide Impella revenue totaled $38.7 million, up 12 percent.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of